Vascular Surgery 2 0 1 2 A N N U A L R E P O R T

Vascular Surgery

Services

2

Surgical Indicators 2

Diagnostic Venous

Unit

3

Meet Our Support

Staff

3

Multidisciplinary

Aortic Program

4

Pediatric Vascular

Disease Program

4

Peripheral Arterial

Disease Program

5

Venous Health

Program

5

Cardiovascular

Center

6

Livonia Vein Clinic 6

Veterans

Administration

6

Residency and

Fellowship

Programs

7

Students 7

Other Programs 7

Vascular Surgery

Research

8

Clinical Trials 9

Quality Assurance 9

Faculty Updates 10

Development 12

Your Support Makes

a Difference

Acknowledging our

Supporters

12

12

12

Success for Today… Vision for Tomorrow

In This Issue

Vascular Surgery at the University of

Michigan Health System (UMHS) has

realized significant achievements in 2012

in all areas of its core services: patient

care, education, and research.

Patient Care The majority of Vascular Surgery patient

services are provided at the Cardio-

vascular Center (CVC) located in Ann

Arbor, Michigan. We are happy to report

that 95 percent of polled CVC patients

said they would return for another visit.

Similar high ratings extend to our satellite

facility at the Livonia Vein Clinic (LVC),

where polled patients reported an overall

patient satisfaction rating of 96 percent.

Vascular Surgery has also met the UMHS

goal of seeing 80 percent of all new

patients within four weeks of their referral

date. Our vision is to create the best

patient care experience and provide the

most up-to-date and innovative vascular

care possible.

Education As a world-renowned academic center,

we are proud to have under our umbrella a

vascular surgery fellowship program, an

integrated vascular residency program,

and a research fellowship federally funded

by a National Institutes of Health (NIH)

sponsored T-32 training grant. In fact, we

will graduate the first of the original

integrated vascular residents in the

country. Our highly sought-after programs

continue to be competitive and attract the

best and brightest candidates. Our vision

is to continue to provide outstanding

clinical training for future academicians

and leaders in vascular surgery. In the

near future, our training program will be

increasingly competency-based with

simulation playing a more prominent

role.

Research In the areas of clinical and basic

science research, amidst a tentative

economy and uncertainty with federal

sponsors, Vascular Surgery managed to

maintain research operations within the

Conrad Jobst Vascular Research

Laboratories and at our Vascular

Mechanics Laboratory receiving awards

totaling more than $2.3M, which is on

par with the prior year total of $2.4M.

We were also able

to maintain

research spending

at our biomedical

clinics and

laboratories, as well

as with many

research

collaborators. Our

vision is to

improve the

human condition by discovery through

research on means to prevent, cure,

and lessen the burden of vascular

disease, and provide an arena to train

future vascular surgeons and scientists.

As we build on our solid foundation,

Vascular Surgery looks forward to

continued success and achievement.

Thomas Wakefield, MD

Section Head

V S ascular urgery

A section of the

Department of Surgery

Vascular Surgery Services As caregivers, our attention never diverts

from providing the best patient care

experience, which not only means achieving

the best possible surgical outcomes, but also

ensuring that the initial clinic visit and

subsequent follow-up are conducted with a

standard of excellence that represents the

Michigan Difference. We are happy to report

that during 2012, our clinic visits increased by

118 patients.

Since our move to the CVC in 2007, the

overall number of operative cases has

increased from 1,114 cases to 1,426 cases in

2012, representing a compounded annual

growth rate (CAGR) of 4.2 percent. With regard

to the patient experience, the University of

Michigan Health System measures patient

satisfaction via a patient survey with questions

evaluating a variety of categories. Survey

results in 2012 reflected the following

satisfaction ratings: scheduling (84 percent),

general customer service (91 percent), quality

of facility (89 percent), and pain management

(85 percent).

venous surgical procedures and outcomes are

presented below. In 2012, we began recording our

complications via the Vascular Inventory

Collaborative (VIC) Registry. Vascular and

Procedural

Indicators Target

Achievement

Level

Freedom From

Mortality 96% 97%

Freedom From

Myocardial In-

farctions 96% 97%

Freedom From

AAA (Abdominal

Aortic Aneurysm)

Open (Mortality) 96% 97%

Arterial Procedures Venous Procedures

Surgical Indicators

CVC Livonia Total

FY10: 7,268 3,162 10,430

FY11: 8,582 3,487 12,069

FY12: 8,761 3,426 12,187

0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

2007

1,114 Cases

2012

1,426 Cases

CAGR 4.2%

Vascular Operative Cases

Clinic Cases

Procedural

Indicators Target

Achievement

Level

Freedom From

Wounds 84-99% 97%

Freedom From

DVTs (Below The

Knee) 95-98% 97%

Freedom From

EHIT

(Endovenous

Heat Induced

Thrombus) 97% 97%

P A G E 2 2 0 1 2 V A S C U L A R S U R G E R Y

Diagnostic Vascular Unit The Diagnostic Vascular Unit (DVU)

underwent significant changes in 2012,

beginning with the addition of a third shift to

accommodate an increase in both patient

volume and requests for emergent studies. Our

full-service clinical diagnostic labs perform

approximately 2,100 tests every month, which

includes both inpatient and outpatient

procedures.

In addition, the DVU continued annual

screenings for both venous and arterial

disease. The venous screening, which tests for

deep vein thrombosis and venous insufficiency,

resulted in more than 100 new patients at both

the Livonia Vein Clinic (LVC) and the DVU.

Thirteen of these new patients resulted in

operative cases. The DVU and Peripheral Artery

Disease (PAD) program offered a joint

screening for peripheral arterial disease,

abdominal aortic aneurysm, and carotid

disease. Of the 86 patients seen, eight were

found to have disease.

These diagnostic

screenings provide us

with proactive measures

to help identify and treat

vascular diseases earlier

and with better results,

as well as provide

outreach services to the

community.

The DVU at the University Hospital,

Cardiovascular Center, Domino Farms, and

Briarwood received accreditation in venous,

arterial, and cerebrovascular testing by the

Intersocietal Accreditation Commission (IAC)

Vascular Testing. This is the first all four

locations have received this accreditation.

Meet Our Support Staff Our exemplary services could not have been provided had it not been for our top-quality clinic

and administrative staff.

“Our annual arterial and venous

screening events allow us to

reach out to the community,

raise awareness and establish

care for many vascular disease

processes that often go

undiagnosed.”

- Sandy Brown, MA, RDMS, RVT

Physician Assistants

David Allis, PA-C

Amy Ashlin-McSween, PA-C

Deborah Rutherford, PA-C

P A G E 3 2 0 1 2 V A S C U L A R S U R G E R Y

Left to right: Ann Luciano, NP; Raquel Clayton, RN; Becky Bertha, RN;

Dawn Skvarce; Clare Harris, NP; Sharon Landers; Michele Kantola, NP;

Susan Young, RN; Charlene Minard, RN; Elaine Fellows, NP; and

William Bill LaForge, RN.

Schedulers

Sharon Landers

Dawn Skvarce

OR Nursing Staff

Gloria McInturff, RN

Kelly Chiles, RN

Ann Flaton, RN

Jennifer Martz, CST

Cheryl Rutan, RN

Kate Tobiczyk, RN

Nurse Practitioners

Elaine Fellows, NP

Clare Harris, NP

Michele Kantola, NP

Ann Luciano, NP

Clinical Nurses

Becky Bertha, RN

Raquel Clayton, RN

Bill LaForge, RN

Charleen Minard, RN

Susan Young, RN

Administrative Staff

Greer Peters - Eshkanian

Sandra Martin

Pam Moss

Duwana Villemure

Multidisciplinary Aortic Program

experience with these children. The operative

management of children with complex arterial

disease now numbers more than 225. In the

past year, 23 pediatric-aged patients

underwent corrective vascular surgery. They

came from Western Europe, the Middle East,

and many major children’s hospitals in Canada

and across the United States.

The expert care of complex arterial diseases

in children is an essential part of the

University’s Vascular Surgery practice and has

been a visible contribution to the Michigan

Difference.

Clinical Trial (N-TA3CT) for the medical

management of small aneurysms. Seth Waits

entered the research laboratory as the

sponsored aortic

research fellow

studying failure

to rescue after

AAA repair.

Not only is the

MAP excelling in

patient care and

research, but

also in sponsoring a multidisciplinary case

conference. This continues to have broad

attendance and further contributes to

outstanding patient care.

P A G E 4

Since its embryonic origin nearly three

decades ago, the Pediatric Vascular Disease

Program at University of Michigan has become

the country’s most common destination for

children in need of surgical management of

occlusive or aneurysmal diseases of the

abdominal aorta and its branches. The

Program includes a multidisciplinary team led

by vascular surgeons Dawn Coleman, MD,

Jonathan Eliason, MD, and James Stanley, MD.

The team partners with physicians from the

specialties of interventional radiology, pediatric

nephrology, intensive care, and anesthesia, as

well as with nurses and social workers with

broad knowledge of this group of patients.

In 2006, the largest reported experience

with pediatric renovascular hypertension

caused by renal artery obstructions emanated

from this Program. Two years later, in 2008,

the world’s largest experience with childhood

abdominal aortic coarctation (narrowing) was

reported by this Program. In late spring 2013,

the Program’s activity with extremity arterial

reconstructions in preadolescent boys and girls

will be presented before the Society for

Vascular Surgery, and when published will

represent the world’s largest reported

Pediatric Vascular Disease Program

Vascular Surgery’s contribution to the

Cardiovascular Center’s Multidisciplinary Aortic

Program (MAP) continues to demonstrate

excellence in surgical outcomes for aortic

diseases. In 2012, 99 patients underwent

open or endovascular aneurysm repair for

complex abdominal aortic aneurysms. The 30-

day mortality for endovascular AAA repair was

1.4 percent, while the 30-day mortality for

open AAA repair was 3.0 percent.

In the area of aortic research, nine FDA-

regulated and two National Institutes of Health

(NIH)-sponsored trials, along with two

Department of Defense (DOD) contacts, were

awarded during the last two years. These

include the fenestrated endograft trial by Cook

Medical and the NIH-sponsored Non-Invasive

Treatment of Abdominal Aortic Aneurysm

2 0 1 2 V A S C U L A R S U R G E R Y

Left: Preoperative image of a young girl whose aorta was

absent with blood flow to her kidneys and lower extremi-

ties being supplied by multiple web-like collateral vessels.

Right: Postoperative image of newly constructed aorta

with branches to both kidneys and the vessels going to

her lower extremities.

Annual AAA Cases

2007 2008 2009 2010 2011 2012

110 98 115 100 97 99

85

90

95

100

105

110

115

120

Venous Health Program

Peripheral Arterial Disease Program

Innovative treatments include:

radiofrequency ablations/laser ablations for

superficial venous reflux,

phlebectomies using Trivex

technique (available in only

two other sites in Michigan

and only 150 sites

nationally) for the removal

of large and extensive

varicose veins,

pharmacomechanical

thrombolysis for aggressive iliofemoral venous

thrombosis, and recanalization of central veins

to treat significant chronic venous

insufficiency. The yearly volume of Venous

Health patients continues to rise.

The Venous Health Program is a

multidisciplinary, centralized, patient-centered

program that provides full service for the entire

spectrum of a patient’s venous disease. The

program features sub-specialty care,

establishing a uniform treatment approach.

Under the leadership of Clare Harris, NP, the

Venous Health Program involves

interdisciplinary faculty from Vascular Surgery,

Vascular Medicine, Interventional Radiology,

and the Livonia Vein Center.

P A G E 5

The Peripheral Arterial Disease (PAD)

program is a truly multidisciplinary program

with representatives from Vascular Surgery,

Interventional Radiology, Cardiology, and

Vascular Medicine. This is the only such

program in the country where cases are

discussed, optimal management strategies are

developed, and case management is shared

across these disciplines.

The program has a standardized outpatient

management approach, increased access to

wound care and pain management services,

and coordinated efforts that have resulted in

improvements in procedural complications and

guideline-recommended medical therapy. Due

to the dedication of our staff, under the

leadership of Ann Luciano, NP, patients and

referring physicians have utilized the program,

and percutaneous and surgical case volume of

all the participating disciplines have increased

significantly.

More specifically, the PAD clinic continues

to meet its goals of seeing new patients within

one week of referral. Free PAD screening in

September 2012 was a success and clinic

satisfaction scores are

greater than 90 percent.

The PAD program has

shared its care

protocols, including

statin use and hydration

practices, with other

disciplines within the

hospital. PAD program

staff have participated in site visits to other

hospital centers in

Southeastern

Michigan to share

their program

experiences. Quarterly

PAD morbidity and

mortality staff

meetings are held,

with all areas

conducting PAD procedures or caring for PAD

patients.

2 0 1 2 V A S C U L A R S U R G E R Y

Percent of Effort By Service

PAD Fiscal Year Stats

Note: NP: New Patient; RV: Returning Visit; H&P: Pre-

operative visit; POV: Post-operative visits.

Venous Health Program Fiscal Year Stats

34% 23%

43%

Cardiology

InterventionalRadiology

Vascular Surgery

17%45%

38%

Cardiology

InterventionalRadiology

Vascular Surgery

Percent of Effort By Service

The Veterans Administration (VA) hospital

remains a stalwart of clinical teaching for

residents and fellows. Vascular Surgery’s

effort is headed up by Peter Henke, MD,

Guillermo Escobar, MD, and Katherine

Gallagher, MD. Research activity is pending

Institutional Review Boards (IRB) and patient

safety information officer approval regarding

the Aastrom Stem Cell trial for PAD, for which

Peter Henke, MD is the local primary

investigator. Peter Henke, MD and John

Rectenwald, MD are also co-investigators at the

VA for the ATTRACT trial, a NIH-sponsored trial

evaluating the role of pharmacomechanical

thrombolysis versus best medical management

in iliofemoral DVT. In 2012, the VA Hospital’s

Vascular Surgery clinic treated 576 out-patients

and 101 in-patients. The Vascular Lab saw

2,781 out-patients and 817 in-patients.

Cardiovascular Center

The Livonia Vein Center (LVC) serves as an

initial triage for the University of Michigan

Venous Program and is an outpatient

procedural site.

Approximately 30

to 40 percent of

new patient

referrals to the

CVC’s Venous

Program come

from the LVC.

This past year,

the LVC in-

creased the total

number of new patients seen in a single year

and continues to pursue new marketing

events in an effort to reach all surrounding

communities. The LVC received the UMHS

Patient Satisfaction Award in spring and fall

2012 for overall patient satisfaction above

95 percent. This marks the third consecutive

year in which the LVC has achieved the

award. Lisa Pavone, MD, and Emily

Cummings, MD, both participated in the

Varisolve research study in 2012, giving

them the opportunity to learn foam

sclerotherapy. Future plans are to expand the

LVC into the Troy/Birmingham region in 2013

with a second location. The site would be

staffed with practitioners who currently

operate the LVC, including Lisa Pavone, MD,

and Emily Cummings, MD, as well as

incremental mid-level providers. A strategic

plan is currently under way, with a desire to

launch the second site as early as possible.

The expansion will increase demand for the

Venous Program at the CVC.

Veterans Administration

Livonia Vein Clinic

Vascular Surgery is an integral part of the

Cardiovascular Center, which includes 308

university physicians and scientists as active

CVC members. The CVC’s clinical and research

programs continued to grow in 2012. In

addition to the CVC’s unmatched facilities,

considerable funding for new ventures has

been available for years from a transformative

gift from the family of Samuel and Jean

Frankel. In 2012, discussions commenced

regarding a public celebration of their

$50,000,000 largesse and the opportunity to

name the CVC after this generous family.

Vascular Surgery is proud to be part of what in

future years will be known as the University of

Michigan Samuel and Jean Frankel

Cardiovascular Center.

2 0 1 2 V A S C U L A R S U R G E R Y P A G E 6

P A G E 7

Our student mentoring program is a

tangible and visible sign of our absolute

commitment to the future of Vascular Surgery.

Thirty-five M3 students rotated into

Vascular Surgery for the 2011-2012 Clerkship

Residency and Fellowship Programs

Other Programs

American Board of Surgery’s qualifying and

certifying examinations. We are proud to

announce that our first integrated vascular

resident, Frank Vandy, MD, will graduate in

June 2013.

year. This program continues to stimulate

student interest in Vascular Surgery. Two

University of Michigan students have matched

into Vascular residency programs, and one into

our integrated Vascular residency program.

Students

In addition to scholarly instruction, Vascular

Surgery sponsored the Milton E. Bryant lecture

in 2012. The distinguished Robert M. Zwolak,

MD, Professor of Surgery, Dartmouth Medical

School, presented “The Patient-Centered Out-

comes Research Institute: Legislation, Roll-out,

Impact.” In partnership with the Conrad Jobst

Vascular Institute in Toledo, Vascular Surgery

co-sponsored the annual Conrad Jobst Lecture,

which featured a keynote address by Gregory

L. Moneta, MD. His discussion, titled “The Ve-

nous Wars…Wins…Losses…Ties,” was a rous-

ing event that sparked tremendous debate sur-

rounding the ethics and decisions of using clin-

ical trials for the treatment of illness.

Vascular Surgery Residents and Fellows. Front Row (left to right):

J. Rectenwald, MD (Program Director); S. Arya, MD (Fellow); F.

Vandy, MD (Chief Resident); T. Wakefield, MD (Section Head).

Back Row (left to right): N. Osborne, MD (Fellow); T. Chen, MD

(Year 2 Resident); D. Campbell, MD (Year 3 Resident); D. Horne,

MD (Year 1 Resident); and J. Knepper, MD (Year 4 Resident).

NIH-sponsored T-32 Training Grant Fellows. Left to right:

T. Shih, MD; A. Obi, MD; M. Girotti, MD; A. Gonzalez, MD.

2 0 1 2 V A S C U L A R S U R G E R Y

Vascular Surgery’s training programs

continue to be among the most sought-

after programs in the nation, enabling us

to match highly competitive trainees to our

programs. Our residents and fellows

continue to excel on their VSITE, SPE, and

Greenfield Award

June 6, 2013

Conrad Jobst Annual Lecture

September 19-20, 2013

Bryant Lecture

April 11-12, 2013

P A G E 8

Vascular Surgery Research Vascular Surgery Research had a strong

year, with significant research endeavors and

scholarly pursuits. Examples of Vascular

Surgery funding opportunities include:

Guillermo Escobar’s, MD, CVC McKay

Research Grant to evaluate the effects of

iodinated contrast dye in a rodent model, as

well as in humans. Jose Diaz, MD, was

awarded a CVC McKay Research Grant to

study the effect of rosuvastatin in deep vein

thrombosis. He also obtained funding from

ATP Therapeutics to evaluate the

antithrombotic efficacy of APT 402 in a venous

thrombosis model. Katherine Gallagher, MD,

secured funding as a recipient of the Taubman

Scholar Award as well as the Wylie Research

Award.

Scholarly activity within Vascular Surgery

Research was outstanding, with 94 peer-

reviewed publications, 29 presentations at

international, national, and regional

conferences, and 22 book chapters written by

members.

Conrad Jobst Vascular Research Laboratories April 2012 brought much-needed changes

to the Conrad Jobst Vascular Research

Laboratories at the University of Michigan. The

entire Conrad Jobst Vascular Research

Laboratory complex, consisting of seven

separate but integrated units, was moved

from its original location in the Medical

Science Research Building II (MSRB) to the

new North

Campus

Research

Complex

(NCRC). The

move was

under the

direction of

Daniel Myers,

DVM, the head

of the Conrad

Jobst Vascular

Research Laboratories. This consolidation has

allowed the researchers an opportunity to

better collaborate on studies and to share

resources, thus containing costs.

Positive changes in the Conrad Jobst

Vascular Research Laboratories have been

noticed by potential donors visiting the new

location. These updated and expanded

facilities were instrumental in obtaining two

DOD grants as well as the $411,000 Bristol

Myers Squibb grant. Like labs across the

country, the Conrad Jobst Vascular Research

Laboratories will be challenged to obtain

funding during 2013. The laboratories currently

have five national funded government grants,

along with one NIH-sponsored T-32 training

grant.

Aortic Modeling The Vascular Mechanics Laboratory was

moved to new quarters at the NCRC where the

bench-top and computer models for the

experimental study of aortic dissection are

assembled. The laboratory, under the direction

of Ramon Berguer, MD, PhD, is working in

collaboration with Juan Parodi, MD, the

2 0 1 2 V A S C U L A R S U R G E R Y

Left: A mathematical model showing the blood flow in

the distal part of an aortic dissection. Right: A model of

the aorta constructed in a 3D printer.

surgeon responsible for developing the first

endograft to treat aortic aneurysms. The

current work is dedicated to modeling and

providing the mechanical effects of a new

approach (septectomy) to treat acute aortic

dissection.

Through a recently endowed Diethrich

Professorship in Engineering and Vascular

Surgery we have recruited Alberto Figueroa,

PhD, who previously worked at Stanford

developing a successful 3D functional and

anatomical imaging map that can be

generated through computerized

angiographic tomography. Alberto Figueroa,

PhD, is currently the head of Biomedical

Engineering at King’s College in London, UK.

Clinical Trials In 2012, the ongoing challenge of obtaining

IRB approval for retrospective studies was

addressed. With the introduction of new

eRsearch capabilities, these retrospective

studies have been re-assembled into exempt

studies, enabling separate and specific

studies to be combined into larger, more open

exempt studies.

This reduces IRB

approval time while

maintaining the

highest compliancy

standards, and

allows clinicians,

residents, and

fellows a much

faster approval time

for their

retrospective

studies. In 2012,

In October 2007, a quality improvement

registry funded by Blue Cross Blue Shield of

Michigan was initiated. This multi-center,

multi-disciplinary outcome registry — the first

of its kind in the United States — was

designed to improve quality of care and

outcomes. In January 2012, the BMC2

Vascular Interventional Collaborative (VIC )

program started to include open vascular

procedures. The collaborative is led by Peter

Henke, MD, for open surgical cases and

Michael Grossman, MD, for PVI. Quarterly

reports are given to individual physicians,

along with departmental reports indicating

outcomes for surgical procedures. Outcomes

include death, infections, amputations,

myocardial infarctions, and strokes. In the

future, we will be participating in selecting

Quality Assurance

161 patients were enrolled in our clinical

studies from the several hundred that were

screened.

In addition to retrospective studies,

researchers from Vascular Surgery have been

pioneers in the use of alternative contrast

agents such as carbon dioxide (CO2) gas for

safe endovascular aneurysm repair (EVAR) in

patients with impaired kidney function. Well

over 100 patients have had EVAR performed

for AAA using CO2 as a contrast media. Data

suggest it is both technically feasible and safe

to use. Enrique Criado, MD, has performed

more than 150 endovascular aneurysm repairs

using CO2 angiography instead of nephrotoxic,

conventional iodinated contrast angiography.

John Rectenwald, MD, is a primary site

investigator for the National Zenith

Fenestrated Aortic Aneurysm trial. He is also a

local co-investigator with Jonathan Eliason,

MD, on the Noninvasive Treatment of AAA

Intact, a NIH-sponsored multicenter trial.

M2S modules as well. Currently, our venous

data is being entered

into a RedCap database,

and outcomes from that

database are reported to

the CVC dashboard along

with the open surgical

outcomes of arterial

procedures. We will be

partnering with leaders

in the next M2S varicose

vein registry.

P A G E 9 2 0 1 2 V A S C U L A R S U R G E R Y

Left to right: Susan Blackburn, RN,

MBA (Clinical Trial/Research); and

Cathy Stabler, RN, BSN (Quality

Assurance).

CO2 aortography during place-

ment of an endograft for aortic

aneurysm repair.

Faculty Updates

Ramon Berguer, MD

Continues as Editor, Annals of Vascular Surgery (Ann Arbor), and Annales de Chirurgie Vascu-

laire (Paris), and Annales de Cirugia Vascular (Barcelona)

Stopped his clinical practice December 31, 2012, but continues with his strong research ef-

forts

Enrique Criado, MD

Named the inaugural John R. Pfeifer Professor of Vascular Surgery

Dawn Coleman, MD

Started as Assistant Professor in Vascular Surgery at University of Michigan

Emily Cummings, MD

Became a Registered Vascular Technologist through the American Registry for Medical Diag-

nostic Sonography

Serves as a member of the American Venous Forum Ulcer Committee and part of the Venous

Ulcer Guidelines Taskforce

Jose Diaz, MD

Awarded Young Investigator Award at AAA Epidemiology, Genetics, & Pathophysiology Confer-

ence in Danville, PA (co-author, national meeting)

Served as Course Director for international course: Basic Science in DVT. III World Symposi-

um of Advances in Phlebology and Lymphology, BA, Argentina

Vascular Surgery Faculty. Front Row (left to right): R. Berguer, MD; T. Wakefield, MD; J. Stanley, MD; Back Row (left

to right): J. Diaz, MD; J. Rectenwald, MD; E. Cummings, MD; D. Coleman, MD; J. Eliason, MD; P. Henke, MD;

D. Myers, DVM MPH; K. Gallagher, MD; L. Pavone, MD; G. Escobar, MD; and E. Criado, MD.

P A G E 1 0 2 0 1 2 V A S C U L A R S U R G E R Y

Jonathan Eliason, MD

Named the second S. Martin Lindenauer Professor of Vascular Surgery

Received a prestigious Department of Defense grant for his work on the treatment of acute

aortic injury in the field

Serves as Chair of the Membership Committee for the Midwestern Vascular Surgical Society

Guillermo Escobar, MD

Awarded the Arnold G. Coran Award for Excellence in Surgical Teaching

Awarded the Peripheral Vascular Surgery Society Research Grant

Awarded the University of Michigan Cardiovascular Center McKay Research Award

Selected for the Young Surgeons Advisory Committee for the Society of Vascular Surgery

Katherine Gallagher, MD

Awarded the American Heart Association Young Investigator Award, Michigan Chapter

Awarded the Wylie Scholar in Academic Vascular Surgery Award

Received Society for Vascular Surgery Woman’s Leadership Grant

Awarded the University of Michigan Taubman Emerging Scholar Grant and McKay Heart of a

Champion Award

Peter Henke, MD

Named President, American Venous Forum

Serves as Associate Editor of the Research Section of the Journal of Vascular Surgery.

Named President, Michigan Vascular Society

Daniel Myers, DVM

Received American Society of Laboratory Animal Practitioners Excellence in Research Award

Became member of the Frederick A. Coller Surgical Society (first veterinarian to be inducted)

Received 2011 University of Michigan Endowment for Basic Sciences Teaching Award

Lisa Pavone, MD

Appointed to the American College of Phlebology Board

John Rectenwald, MD

Serves as member of the Society for Vascular Surgery Clinical Practice Council

Serves as Chairman, Society for Vascular Surgery Resident & Student Outreach Committee

Serves as member in the Association of Program Directors in Vascular Surgery, Education

Committee

James Stanley, MD

Established the Stanley Professorship in Vascular Surgery

Received the Founder’s Award from the Fibromuscular Dysplasia Society of America

Received the Lifetime Achievement Award, Society for Vascular Surgery

Continues as the Senior Associate Director Medical Arts Program, University of Michigan

Medical School

Thomas Wakefield, MD

Named the inaugural James C. Stanley Professor of Vascular Surgery

Received the 2012 Venous Research Award from the Venous Disease Coalition

Named the University of Toledo School of Medicine Alumnus of the Year

P A G E 1 1 2 0 1 2 V A S C U L A R S U R G E R Y

Development

P A G E 1 2

University of Michigan Vascular Surgery

is pleased to provide you with an annual

update on our successes. Many of these

would not have been possible without our

generous supporters. Please help us realize

Your Support Makes a Difference

Thanks to philanthropic support from

the Jobst and Frankel Foundations, a

tremendous amount of knowledge has

originated from the two laboratories

carrying their names. Also, during the

2012 academic year, Edward (Ted)

Diethrich, a University of Michigan

undergraduate and medical student

alumnus, established a new faculty

position — a Professorship in Biomedical

Engineering in Vascular Surgery — which

will carry his name. Last but not least,

our research is enriched by a generous

gift from the Biardi family and Bud

Stoddard.

Vascular Surgery at Michigan

continues to make a difference, thanks

to our charitable philanthropic

contributors. We are exceedingly grateful

to all those who have helped us maintain

our solid commitment to understanding,

presenting, and treating vascular

disease.

Vascular Surgery is committed to the

betterment of humankind, which is made

possible through ongoing philanthropic

support. Our Doan, Frankel, Handleman,

Lindenauer, Pfeifer, and Stanley

Professorships, for example, set us apart

from our peers. Endowed by generous

patients, friends, and alumni who value the

life-changing accomplishments of academic

vascular surgeons, our Professorships

provide resources and time for their holders

to pursue new and often unchartered

opportunities to advance medicine.

Our educational programs receive

ongoing support from the Bryant-Arnold,

DeWeese, Greenfield, and Lindenauer

funds, each established to benefit our

trainees. Additional endowments enrich our

community with the annual Jobst and

Bryant lectures and the Berguer Lecture on

Ethics, a generous donation made this year.

University of Michigan Cardiovascular Center,

1500 E. Medical Center Dr.

Ann Arbor, MI 48109-5867

Phone: 734.936.5820

2 0 1 2 V A S C U L A R S U R G E R Y

Special thanks goes to Michael

Mulholland, MD, Department of Surgery;

Kim Eagle, MD; David Pinsky, MD; Richard

Prager, MD; James Stanley, MD; and Linda

Larin, Chief Administrative Officer, CVC for

their ongoing support.

Acknowledging Our Supporters

future successes by donating to Vascular

Surgery. Donations may be made by call-

ing (734) 232-6017 or online at

www.giving.umich.edu/give/surgery-

vascular.